Introduction
============

Tibial fractures account for 3--4% of all fractures, and are one of the most common types of fractures in older people ([@b1-etm-0-0-4037]). With the extension of human longevity and bone loss, the incidence rate of osteoporosis and tibial fractures has increased, especially in the aging population, and has become a serious social problem ([@b2-etm-0-0-4037]). Open reduction and internal fixation are usually used for the treatment of tibial fractures. However, a clinical study found that using tourniquets for long periods of time caused compression hemostasis, and after the surgery was completed and the tourniquet was dismantled, patients were often accompanied by varying degrees of ischemia-reperfusion injury of the lower extremities ([@b3-etm-0-0-4037]). The specific postoperative manifestations included lower limb swelling, pain, numbness, minor lower limb necrosis, and soft tissue injury, which severely influenced postoperative recovery and quality of life of patients ([@b4-etm-0-0-4037]).

Studies found that when tourniquets were dismantled and blood supply was restored postoperatively, excessive free radicals in blood attack cells within the tissues that regained blood supply, and caused tissue damage ([@b5-etm-0-0-4037]). This process is known as ischemia-reperfusion injury. The ability to synthesize antioxidative enzymes in ischemic tissue that could scavenge free radicals was impaired, which aggravated tissue injury caused by free radicals after ischemia and reperfusion. Superoxide dismutase (SOD) can clear free radicals and has a protective effect against ischemia-reperfusion injury.

Ischemia-reperfusion injury of the lower extremities is often accompanied by different levels of release of inflammatory cytokines from neutrophils ([@b6-etm-0-0-4037]) such as interleukin (IL)-6 and TGF-α. In addition, it can decrease SOD activity *in vivo*. Therefore, during anesthesia, maintaining the highest possible levels of SOD activity can help to reduce the release of inflammatory cytokines and inflammatory cell infiltration, and therefore represents an important method of improving the prognosis of patients ([@b7-etm-0-0-4037]).

Based on previous research, etomidate and propofol were applied respectively for anesthesia maintenance during surgery in the two groups of patients with tibial fracture, and the effects of the two anesthetics on inflammatory factors and SOD activity were analyzed ([@b8-etm-0-0-4037]).

Patients and methods
====================

From December 2013 to June 2015, 60 patients with tibial fractures that conformed with the surgical indications of open reduction and internal fixation were selected. Patients were randomly divided into two groups, the observation group and the control group. There were no significant differences in age, body mass index (BMI), and gender ratio between the two groups (P\>0.05) ([Table I](#tI-etm-0-0-4037){ref-type="table"}).

### Inclusion criteria

The inclusion criteria were as follows: i) Patients were diagnosed with tibial fractures though clinical and imaging examinations; ii) age of patients was 18--60 years; and iii) manual reduction was invalid, or patients were accompanied by tibial structural damage and manual reduction could not be carried out.

### Exclusion criteria

The exclusion criteria were as follows: i) Patients taking immunosuppressants; ii) patients with severe and/or chronic bacterial and/or viral infections; iii) patients with autoimmune diseases; iv) patients with connective tissue diseases; v) patients with malignant tumors; vi) patients with liver and kidney dysfunction; vii) patients with chronic muscle disease; viii) patients with peripheral vascular disease, chronic heart failure, thyroid disease, severe trauma that occurred half a year before the study, and a history of surgery; ix) patients with diabetes; x) patients with grade III and IV New York Heart Association classification; xi) hormone replacement therapy or other immune modulators were given to patients within the past 6 months; xii) patients and their families could not cooperate; and xiii) patients with a history of mental illness ([@b2-etm-0-0-4037]).

### Specimen collection

Fasting venous blood (3 ml) was collected in the early morning and placed in ordinary plastic tubes. Next, 1.8 ml venous blood was transferred to anticoagulant tubes containing 0.2 ml 3.8% sodium citrate. Specimens were centrifuged (1,200 × g) within 1 h for 10 min. Serum or plasma were separately extracted and stored in 0.5 ml Eppendorf tubes at −30°C, and used within 1 month.

### Measurement of serum TNF-α, IL-1, and IL-6 by ELISA

Before surgery (T0), before surgery was completed and anesthesia was stopped (T1), 24 h after surgery (T3), 48 h after surgery (T4), and 1 week after surgery (T5), the levels of tumor necrosis factor (TNF)-α, IL-1, and IL-6 was measured by enzyme-linked immunosorbent assay (ELISA). All reagents in this study were from Wuhan Boster Biological Engineering Co. (Wuhan, China) and used according to the manufacturer\'s instructions.

### Measurement of SOD activity

Before surgery (T0), before surgery was completed and anesthesia was stopped (T1), 24 h after surgery (T3), 48 h after surgery (T4), and 1 week after surgery (T5), the measurement of serum SOD activity was performed strictly in accordance with the instructions of the SOD kit (Nanjing Institute of Biological Engineering, Nanjing, China).

### Anesthesia

i\) For anesthesia induction, the two groups of patients were treated with remifentanil injection (0.2--0.3 µg/kg), cisatracurium besilate (500 µg/kg, H20060927; Jiangsu Hengrui Medicine Co., Ltd., Lianyungang, China), and midazolam injection (0.5--0.1 mg/kg, H19990027; Jiangsu Enhua Pharmaceutical, Xuzhou, China). Etomidate (3 mg/kg) was used in the observation group, and propofol (1 mg/kg) was used in the control group for anesthesia induction; and ii) for intraoperative maintenance, continuous micro syringe pump infusion of propofol \[3--6 mg/(kg·h)\] and remifentanil (0.1--0.25 µg/kg/min, remifentanil hydrochloride injection, batch no. of product, 6130314; Humanwell Pharmaceutical Co., Ltd., Yichang, China) were applied for intravenous anesthesia in the control group. Continuous micro syringe pump infusion of etomidate \[3--6 mg/(kg·h); Jiangsu Enhua Pharmaceutical\] and remifentanil (0.1--0.25 µg/kg/min) were applied for intravenous anesthesia in the observation group.

### Statistical analysis

SPSS 20.0 software was used for data analysis. Data are presented as mean ± standard deviation (SD), independent sample t-test was used for comparisons between groups, and a paired t-test was used among groups. P\<0.05 was considered statistically significant.

Results
=======

### The comparison of serum SOD activity between the two groups at six time points (mean ± SD)

The serum SOD activity between the two groups at the six time points were recorded and compared. Beginning at T3, SOD levels in the control group decreased significantly compared with the observation group (P\<0.05) ([Table II](#tII-etm-0-0-4037){ref-type="table"} and [Fig. 1](#f1-etm-0-0-4037){ref-type="fig"}).

### The comparison of serum levels of TNF-α, IL-1, and IL-6 between the two groups at six time points (mean ± SD)

The comparison of the levels of TNF-α, IL-1, and IL-6 in serum at the six time-points indicated that, beginning from T2, the serum levels of TNF-α, IL-1, and IL-6 in the observation group decreased significantly compared with the control group (P\<0.05) ([Table III](#tIII-etm-0-0-4037){ref-type="table"}).

### Comparison of postoperative complications between the two groups of patients

The postoperative complications of the two groups of patients were compared, demonstrating that the symptoms, including lower limb pain, numbness, and coldness, were significantly less in the observation compared with the control group (χ^2^=43.78, P\<0.05) ([Table IV](#tIV-etm-0-0-4037){ref-type="table"}).

Discussion
==========

Etomidate belongs to the class of nonbarbiturate intravenous sedatives, and is a form of imidazole derivative used in general anesthesia ([@b9-etm-0-0-4037],[@b10-etm-0-0-4037]). It is believed that etomidate has a better protective effect when patients with cardiovascular disease are under anesthesia for surgery. When using routine clinical doses, heart rate, mean arterial pressure, mean pulmonary arterial pressure, pulmonary capillary wedge pressure, central venous pressure, cardiac stroke volume, cardiac index, pulmonary vascular resistance, and peripheral vascular resistance between cardiac patients and normal patients had almost no differences. Etomidate exerts its pharmacological function through the GABA~A~ receptors. The hypnotic effects of etomidate are mediated through the β2 and β3 subunits of GABA~A~ receptors rather than the α1 subunit, and GABA~A~ receptor antagonists can antagonize the effects ([@b11-etm-0-0-4037],[@b12-etm-0-0-4037]). In our study, serum SOD activity and the levels of inflammatory factors of the two groups at six time points were compared. Compared with the control group, the levels of serum SOD and TNF-α, IL-1, and IL-6 released by neutrophils after ischemia-reperfusion injury in the observation group (treated with etomidate) were significantly decreased (P\<0.05). These results were similar to a previous study, which showed that in ischemia-reperfusion injury, because of ischemia, the levels of IL-10 and TNF-α increased, which can increase T lymphocyte infiltration ([@b13-etm-0-0-4037]). SOD activity was also an important factor. SOD is an active substance derived from cells, that can eliminate harmful substances produced during metabolic processes, and has an anti-aging effect. After tibial fracture, because of ischemia and hypoxia, a large amount of oxygen-free radical are generated in local tissue and in circulation. SOD is a primary substance that scavenges reactive oxygen species (ROS) ([@b14-etm-0-0-4037]). We found that ROS levels increased significantly in patients with tibial fracture, which may be related to ischemia-reperfusion injury after using tourniquets for a long period of time.

Yu *et al* found that etomidate had a protective effect on ischemia-reperfusion injury of the spinal cord induced by interruption of the rabbit aorta ([@b15-etm-0-0-4037]). Ergün *et al* found that anesthetic doses of propofol, ketamine, and etomidate had protective effects on ischemia-reperfusion injury of skeletal muscle, and there were no obvious differences between them ([@b16-etm-0-0-4037]). However, Harman *et al* employed an intrauterine model of hypoxia of fetal rats, simulated by clamping the ovarian uterine artery of pregnant rats, and etomidate, midazolam, propofol and other commonly used anesthetic drugs were used during the intervention. The results indicated that only propofol and midazolam had neuroprotective effects, and significant neuroprotective roles of other narcotic drugs were not observed ([@b17-etm-0-0-4037]). Yuzer *et al* showed that propofol and thiopental can significantly reduce ischemia-reperfusion injury of the kidney. The protective effects of these drugs may be attributed to the antioxidant functions of narcotic drugs. Their results showed that anesthesia with propofol and thiopental had good effects on improving renal function ([@b18-etm-0-0-4037]). We believe the controversy surrounding these findings may be attributed to surgical approaches, injury of organs, and ischemia-reperfusion injury, although further animal studies are required for validation.

We observed that the postoperative length of stay in hospital of patients in the observation group was significantly shorter than that of the control group, and the occurrence rate of anesthesia complications was significantly decreased (P\<0.05). We hypothesized that inflammatory cytokines are released from ischemia-reperfusion injury of the lower limbs and that the levels of ROS in the body affect the functions of the lower extremities. While etomidate had a good effect on reducing the levels of ROS and the release of inflammatory factors ([@b16-etm-0-0-4037]--[@b23-etm-0-0-4037]), the specific mechanisms still need to be explored by *in vivo* and *in vitro* experiments.

In conclusion, tourniquets are routinely applied for hemostasis during surgery for open tibial fractures. The intraoperative use of etomidate for maintaining sedation can effectively decrease serum SOD levels and the release of inflammatory factors after ischemia-reperfusion injury. In addition, it can effectively decrease the occurrence rate of complications from anesthesia after surgery.

![Beginning from T2, SOD activity in the observation group was significantly higher than in the control group (\*P\<0.05). SOD, superoxide dismutase.](etm-13-03-0971-g00){#f1-etm-0-0-4037}

###### 

Baseline parameters of patients.

  Groups        Cases   Age (years)   BMI (kg/m^2^)   Gender ratio (male/female)
  ------------- ------- ------------- --------------- ----------------------------
  Observation   30      52.4±4.3      22.3±2.2        24/25
  Control       30      49.8±11.2     23.2±1.5        28/21
  T-value       --      0.87          0.44            0.41
  P-value       --      0.15          0.65            0.57

BMI, body mass index.

###### 

The comparison of serum SOD activity between the two groups at the six time points (mean ± SD).

  Groups        Cases   T0          T1         T2          T3          T4          T5
  ------------- ------- ----------- ---------- ----------- ----------- ----------- -----------
  Observation   30      7.02±0.75   5.33±2.2   6.48±1.38   5.58±3.28   5.29±0.48   5.47±0.82
  Control       30      8.27±0.48   4.42±1.5   3.27±0.58   2.37±0.48   2.21±0.42   2.60±0.47
  T-value       --      0.87        0.44       19.42       10.78       12.84       11.38
  P-value       --      0.15        0.65       0.004       0.005       0.006       0.007

SOD, superoxide dismutase.

###### 

The comparison of serum levels of TNF-α, IL-1, and IL-6 between the two groups at the six time points (mean ± SD).

  Title           Groups        Cases   T0           T1          T2           T3           T4           T5
  --------------- ------------- ------- ------------ ----------- ------------ ------------ ------------ ------------
  TNF-α (ng/ml)   Observation   30      12.02±0.75   25.33±2.2   16.48±3.8    15.58±3.28   15.29±4.8    10.47±8.2
                  Control       30      13.12±0.48   34.42±1.5   33.27±5.8    22.37±0.48   22.21±4.2    20.60±4.7
                  T-value       --      0.87         0.24        18.42        12.78        16.84        17.38
                  P-value       --      0.17         0.62        0.003        0.004        0.005        0.006
  IL-1 (ng/ml)    Observation   30      16.13±5.23   37.4±1.26   20.33±1.33   10.68±2.31   11.03±0.48   9.81±0.38
                  Control       30      15.21±3.28   31.5±0.47   19.42±1.28   15.47±3.28   16.32±2.31   18.82±2.43
                  T-value       --      0.34         0.67        12.47        13.23        14.37        20.38
                  P-value       --      0.78         0.38        0.024        0.021        0.031        0.002
  IL-6 (ng/ml)    Observation   30      4.33±1.23    7.48±3.28   4.33±2.14    3.24±1.24    2.14±2.76    3.28±1.29
                  Control       30      4.18±1.33    8.48±1.24   8.60±1.29    9.03±0.48    8.74±1.27    7.38±2.13
                  T-value       --      0.61         0.52        19.32        21.25        13.24        9.84
                  P-value       --      0.39         0.44        0.002        0.001        0.016        0.023

TNF, tumor necrosis factor; IL, interleukin.

###### 

The comparison of postoperative complications between the two groups of patients.

  Groups        Cases   Lower limb pain   Numbness of the lower limbs   Coldness of the lower limbs   Normal
  ------------- ------- ----------------- ----------------------------- ----------------------------- --------
  Observation   30      2                 5                             3                             39
  Control       30      12                8                             3                             26
  χ^2^ value    --                        43.78                                                       
  P-value       --                        0.032                                                       

[^1]: Contributed equally
